Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): A randomised, double-blind trial

Yi Long Wu, Jin Soo Lee, Sumitra Thongprasert, Chong Jen Yu, Li Zhang, Guia Ladrera, Vichien Srimuninnimit, Virote Sriuranpong, Jennifer Sandoval-Tan, Yunzhong Zhu, Meilin Liao, Caicun Zhou, Hongming Pan, Victor Lee, Yuh Min Chen, Yan Sun, Benjamin Margono, Fatima Fuerte, Gee Chen Chang, Kasan SeetalaromJie Wang, Ashley Cheng, Elisna Syahruddin, Xiaoping Qian, James Ho, Johan Kurnianda, Hsingjin Eugene Liu, Kate Jin, Matt Truman, Ilze Bara, Tony Mok

研究成果: 雜誌貢獻文章同行評審

267 引文 斯高帕斯(Scopus)

指紋

深入研究「Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): A randomised, double-blind trial」主題。共同形成了獨特的指紋。

Medicine & Life Sciences